Skip to main content
Protocol
MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy
- Michael Thomas,
- Petros Christopoulos,
- Wade T Iams,
- Julien Mazières,
- Alexis B Cortot,
- Nir Peled,
- Gabriele Minuti,
- Egbert F Smit,
- Francois Audhuy,
- Karin Berghoff,
- S Peter Eggleton,
- Frank Fries,
- Maike Hildenbrand,
- Peter Liu,
- Seyed Hamidreza Mahmoudpour,
- Christoph Menzel, and
- Dina Oksen
e240127
Published Online:21 January 2025
Short Report
Longer disease progression milestone-free time in people with amyotrophic lateral sclerosis treated versus not treated with intravenous edaravone: results from an administrative claims analysis
- James D Berry,
- Melissa Hagan,
- Jeffrey Zhang,
- Ying Liu, and
- Malgorzata Ciepielewska
e240007
Published Online:21 January 2025
Research Article
Real-world ePRO use and clinical outcomes using electronic patient-reported symptom monitoring for patients with advanced non-small-cell lung cancer receiving first-line pembrolizumab
- L. Johnetta Blakely,
- Sabine Oskar,
- Ian Kudel,
- Ashley Roush,
- Zoya Shamsi,
- Toni Perry,
- Annette Christianson,
- Brittni Smith, and
- Thomas Burke
e240122
Published Online:17 January 2025
Cost–effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain
- Ruth Álvarez Cabellos,
- Jon Cacicedo,
- Susana Redondo Capafons,
- Heidi De los Santos Real,
- Miriam Brines Julián,
- Darío Rubio-Rodríguez, and
- Carlos Rubio-Terrés
e240116
Published Online:10 January 2025
A real-world analysis of antidepressant medications in US veterans aged 60 years and older: a comparative analysis
- Ryan D Pittman,
- S Scott Sutton,
- Joseph Magagnoli, and
- Tammy H Cummings
e240187
Published Online:21 January 2025
Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema
- Maureen Watt,
- Rachel Goldgrub,
- Mia Malmenäs, and
- Katrin Haeussler
e240110
Published Online:21 January 2025
Systematic Review
The burden of Alagille syndrome: uncovering the potential of emerging therapeutics – a comprehensive systematic literature review
- Philip Bufler,
- Robin Howard,
- Lucia Quadrado,
- Guy Lacey,
- Jolan Terner-Rosenthal,
- Andrea Goldstein,
- Pamela Vig, and
- Deirdre Kelly
e240188
Published Online:14 January 2025
Review
Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from China
- Hua Zhong,
- Jun Lu,
- Mengzhao Wang, and
- Baohui Han
e240043
Published Online:17 December 2024